Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Medtronic (MDT)
NYSE:MDT
Holding MDT?
Track your performance easily
MDT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$75.96 - $92.68
Previous Close$81.03
Volume10.71M
Average Volume (3M)5.83M
Market Cap
$103.90B
Enterprise Value$124.46B
Total Cash (Recent Filing)$7.99B
Total Debt (Recent Filing)$28.33B
Price to Earnings (P/E)24.7
Beta0.63
Next Earnings
Feb 18, 2025EPS Estimate
$1.36Last Dividend Ex-Date
Dec 27, 2024Dividend Yield3.43%
Share Statistics
EPS (TTM)3.28
Shares Outstanding1,282,285,681
10 Day Avg. Volume5,766,328
30 Day Avg. Volume5,834,134
Standard Deviation0.07
R-Squared0.43
Alpha-0.00989
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)2.14
Price to Sales (P/S)3.11
Price to Cash Flow (P/CF)26.80
P/FCF Ratio39.70
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.77
Enterprise Value/Gross Profit5.89
Enterprise Value/Ebitda14.55
Forecast
1Y Price Target
$95.93Price Target Upside18.39% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering17
Medtronic News
Bulls Say, Bears Say
Bulls Say
Earnings GuidanceUpdated guidance for top-line organic growth and earnings per share was raised, indicating confidence in future performance.
Product LaunchesMedtronic's ongoing and upcoming cadence of new product launches should sustain a mid-single-digit revenue growth trajectory.
Revenue GrowthMedtronic's revenue growth outpaced expectations due to strong performance in cardiovascular, neuro, and diabetes sectors.
Bears Say
Financial PerformanceThe revised +4.75% organic guide (midpoint) is lighter than the +5.2% posted, suggesting the path toward a sustainable faster top-line growth profile will not be linear.
Market CompetitionThe growing popularity of GLP-1 drugs could significantly impact Medtronic's insulin pump sales, with a risk of losing 50% of its market share.
Operational ChallengesMedtronic faces challenges such as inflation, higher labor costs, and higher material costs, which have led to a decline in net profits and profit margins.
---
Ownership Overview
0.07% Insiders
24.64% Mutual Funds
18.79% Other Institutional Investors
36.39% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MDT FAQ
What was Medtronic’s price range in the past 12 months?
Medtronic lowest stock price was $75.96 and its highest was $92.68 in the past 12 months.
What is Medtronic’s market cap?
Currently, no data Available
When is Medtronic’s upcoming earnings report date?
Medtronic’s upcoming earnings report date is Feb 18, 2025 which is in 51 days.
How were Medtronic’s earnings last quarter?
Medtronic released its earnings results on Nov 19, 2024. The company reported $1.26 earnings per share for the quarter, beating the consensus estimate of $1.25 by $0.01.
Is Medtronic overvalued?
According to Wall Street analysts Medtronic’s price is currently Undervalued.
Does Medtronic pay dividends?
Medtronic pays a Quarterly dividend of $0.699 which represents an annual dividend yield of 3.43%. See more information on Medtronic dividends here
What is Medtronic’s EPS estimate?
Medtronic’s EPS estimate is $1.36.
How many shares outstanding does Medtronic have?
Medtronic has 1,282,285,600 shares outstanding.
What happened to Medtronic’s price movement after its last earnings report?
Medtronic reported an EPS of $1.26 in its last earnings report, beating expectations of $1.25. Following the earnings report the stock price went down -2.957%.
Which hedge fund is a major shareholder of Medtronic?
Among the largest hedge funds holding Medtronic’s share is First Eagle Investment Management LLC. It holds Medtronic’s shares valued at 879M.
---
Medtronic Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$95.93 (18.39% Upside)
$95.93 (18.39% Upside)
Blogger Sentiment
Bullish
MDT Sentiment 94%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 889.1K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▼ 0.8%
Last 30 Days ▼ 0.2%
Last 30 Days ▼ 0.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
3.06%
12-Months-Change
Fundamentals
Return on Equity
8.58%
Trailing 12-Months
Asset Growth
-0.05%
Trailing 12-Months
Company Description
Medtronic
Founded in 1949, Medtronic Plc, a medical technology company, develops, manufactures, distributes, and sells device-based medical therapies and services worldwide. It operates through four segments, including Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The company is headquartered in Dublin, Ireland.
---
MDT Company Deck
---
MDT Earnings Call
Q2 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call demonstrated consistent revenue growth, increased guidance, and strong performance in key segments like diabetes and structural heart. However, challenges such as supply chain interruptions and currency headwinds were noted. Overall, the positive aspects, such as innovation-driven growth and a raised outlook, outweigh the negatives.Read More>---
MDT Net sales Breakdown
36.56% Cardiovascular
29.06% Neuroscience
26.01% Medical Surgical
7.69% Diabetes
0.68% Other operating segment
---
MDT Stock 12 Month Forecast
Average Price Target
$95.93
▲(18.39% Upside)
Technical Analysis
Best Analysts Covering MDT
1 Year
1 Year Success Rate
18/30 ratings generated profit
1 Year Average Return
+7.00%
reiterated a buy rating last month
Copying Matt Miksic's trades and holding each position for 1 Year would result in 60.00% of your transactions generating a profit, with an average return of +7.00% per trade.
---